Even a major company cannot escape action if it fails to follow rules related to infant nutrition and baby food. The Food Safety and Standards Authority of India (FSSAI) has initiated legal action against Nestlé India over alleged violations involving three infant nutrition products.
The action follows an investigation into the company’s products and their advertisements on e-commerce platforms. FSSAI officials examined the claims made in advertisements for products including NAN Excella Pro Stage 1 and Lactogen Pro 1.
What happened?
According to the findings, Nestlé had promoted NAN Excella Pro Stage 1 by highlighting features such as “5 HMOs” and “whey protein.” Similarly, advertisements for Lactogen Pro 1 made specific claims about the whey protein used in the product.
FSSAI sought an explanation from the company regarding these claims. However, the regulator was reportedly not satisfied with Nestlé India’s response.
Officials said that such promotional claims for infant food products must comply with the food safety regulations and advertising restrictions applicable to infant nutrition products.
Why the rules are so strict for baby food?
Infant nutrition is considered a highly sensitive issue because babies depend heavily on their food for healthy growth and development. In India, strict regulations are in place to ensure that parents are not influenced by misleading advertisements or promotional claims while choosing infant food.
The Infant Milk Substitutes, Feeding Bottles and Infant Foods (Regulation of Production, Supply and Distribution) Act, 1992 places restrictions on the advertising and promotion of infant milk substitutes and related products.
The aim of these rules is to ensure that commercial marketing does not influence parents’ decisions about infant feeding.
Nutritional deficiency also under scrutiny
The issue is not limited to advertising claims. FSSAI also found a problem with the nutritional content of one Nestlé follow-up formula product.
A sample was tested in a laboratory, and the Biotin (Vitamin B7) content was found to be below the prescribed requirement. The sample was subsequently sent to a referral laboratory for further testing, where the finding was reportedly confirmed.
Biotin is an important vitamin involved in several essential functions in the body. Since the product did not meet the required nutritional standard, it was considered substandard under the applicable regulations.
Three cases registered
In total, three separate cases have been initiated against Nestlé India. Two cases relate to alleged violations concerning advertising claims, while the third concerns the reported nutritional deficiency in an infant nutrition product.
However, the matter is still under investigation. A final decision will be taken by the competent authority after the relevant legal and regulatory procedures are completed. The development once again highlights the importance of strict quality control and responsible advertising when it comes to products meant for infants.